Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	ABCC1 ABCF1 DDX12P MYO10 PSMC2 RNF213 BTAF1 ASCC3 DDX24 DNAH6 TOP2A DYNC1H1 HSP90AA1	1.18e-05	614	100	13	GO:0140657
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCC1 ABCF1 DDX12P PSMC2 RNF213 BTAF1 ASCC3 DDX24 DNAH6 DYNC1H1 HSP90AA1	1.30e-05	441	100	11	GO:0016887
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR2 RYR3	1.48e-04	4	100	2	GO:0005219
GeneOntologyMolecularFunction	CoA carboxylase activity	ACACB PCCA	3.68e-04	6	100	2	GO:0016421
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR2 RYR3	3.68e-04	6	100	2	GO:0048763
GeneOntologyMolecularFunction	biotin binding	ACACB PCCA	3.68e-04	6	100	2	GO:0009374
GeneOntologyMolecularFunction	ligase activity, forming carbon-carbon bonds	ACACB PCCA	5.13e-04	7	100	2	GO:0016885
GeneOntologyMolecularFunction	clathrin light chain binding	CLTCL1 CLTC	5.13e-04	7	100	2	GO:0032051
GeneOntologyCellularComponent	cell cortex	SHROOM3 MYO10 EXOC3 FRYL NEDD4 DST DLG4 CTNNA2 DYNC1H1	7.28e-05	371	100	9	GO:0005938
GeneOntologyCellularComponent	nuclear protein-containing complex	DDX12P EZH2 DIS3 CREBZF BAP1 RBMXL2 TXNL4A GLE1 TXNL4B RBMX CD2BP2 NUP210 CLTC C1D CSTF3 KMT2A PRKDC ASCC3	8.48e-05	1377	100	18	GO:0140513
GeneOntologyCellularComponent	U5 snRNP	TXNL4A TXNL4B CD2BP2	2.26e-04	25	100	3	GO:0005682
Domain	CPSASE_1	ACACB CPS1 PCCA	1.39e-06	5	98	3	PS00866
Domain	CPSASE_2	ACACB CPS1 PCCA	2.77e-06	6	98	3	PS00867
Domain	CbamoylP_synth_lsu-like_ATP-bd	ACACB CPS1 PCCA	4.83e-06	7	98	3	IPR005479
Domain	BC-like_N	ACACB CPS1 PCCA	4.83e-06	7	98	3	IPR005481
Domain	CPSase_L_D2	ACACB CPS1 PCCA	4.83e-06	7	98	3	PF02786
Domain	Biotin_carb_N	ACACB CPS1 PCCA	4.83e-06	7	98	3	PF00289
Domain	AAA	ABCC1 ABCF1 PSMC2 RNF213 ASCC3 DNAH6 DYNC1H1	1.08e-05	144	98	7	SM00382
Domain	AAA+_ATPase	ABCC1 ABCF1 PSMC2 RNF213 ASCC3 DNAH6 DYNC1H1	1.08e-05	144	98	7	IPR003593
Domain	DIM1	TXNL4A TXNL4B	2.73e-05	2	98	2	SM01410
Domain	Clathrin_H-chain_propeller_rpt	CLTCL1 CLTC	2.73e-05	2	98	2	IPR022365
Domain	Clathrin-link	CLTCL1 CLTC	2.73e-05	2	98	2	PF09268
Domain	-	CLTCL1 CLTC	2.73e-05	2	98	2	2.130.10.110
Domain	Dim1	TXNL4A TXNL4B	2.73e-05	2	98	2	IPR004123
Domain	Clathrin_heavy_chain	CLTCL1 CLTC	2.73e-05	2	98	2	IPR016341
Domain	Clathrin_H-chain_propeller_N	CLTCL1 CLTC	2.73e-05	2	98	2	IPR001473
Domain	DIM1	TXNL4A TXNL4B	2.73e-05	2	98	2	PF02966
Domain	Clathrin_H-chain_link/propller	CLTCL1 CLTC	2.73e-05	2	98	2	IPR016025
Domain	Clathrin_propel	CLTCL1 CLTC	2.73e-05	2	98	2	PF01394
Domain	Clathrin_H-chain_linker_core	CLTCL1 CLTC	2.73e-05	2	98	2	IPR015348
Domain	-	ACACB CPS1 PCCA	3.86e-05	13	98	3	3.40.50.20
Domain	ATP_GRASP	ACACB CPS1 PCCA	4.89e-05	14	98	3	PS50975
Domain	ATP-grasp	ACACB CPS1 PCCA	4.89e-05	14	98	3	IPR011761
Domain	PreATP-grasp_dom	ACACB CPS1 PCCA	4.89e-05	14	98	3	IPR016185
Domain	-	ACACB CPS1 PCCA	6.09e-05	15	98	3	3.30.1490.20
Domain	ARM-type_fold	RELCH CLTCL1 FRYL BTAF1 RYR3 PPP4R3A NCAPG CLTC PRKDC	7.33e-05	339	98	9	IPR016024
Domain	Rhs_assc_core	TENM2 TENM4	8.15e-05	3	98	2	IPR022385
Domain	Clathrin_H-chain_linker	CLTCL1 CLTC	8.15e-05	3	98	2	IPR012331
Domain	Ryanodine_rcpt	RYR2 RYR3	8.15e-05	3	98	2	IPR003032
Domain	Ryanrecept_TM4-6	RYR2 RYR3	8.15e-05	3	98	2	IPR009460
Domain	RyR	RYR2 RYR3	8.15e-05	3	98	2	PF02026
Domain	RR_TM4-6	RYR2 RYR3	8.15e-05	3	98	2	PF06459
Domain	CLH	CLTCL1 CLTC	8.15e-05	3	98	2	SM00299
Domain	Ryan_recept	RYR2 RYR3	8.15e-05	3	98	2	IPR013333
Domain	ATP_grasp_subdomain_1	ACACB CPS1 PCCA	1.08e-04	18	98	3	IPR013815
Domain	-	ACACB CPS1 PCCA	1.08e-04	18	98	3	3.30.470.20
Domain	EF-hand_1	VSNL1 LCP1 RYR2 RYR3 EFHC2 DST	1.50e-04	152	98	6	PF00036
Domain	Tox-GHH_dom	TENM2 TENM4	1.62e-04	4	98	2	IPR028916
Domain	EYA_dom	EYA4 EYA2	1.62e-04	4	98	2	IPR006545
Domain	Tox-GHH	TENM2 TENM4	1.62e-04	4	98	2	PF15636
Domain	Ten_N	TENM2 TENM4	1.62e-04	4	98	2	IPR009471
Domain	Ten_N	TENM2 TENM4	1.62e-04	4	98	2	PF06484
Domain	EYA_fam	EYA4 EYA2	1.62e-04	4	98	2	IPR028472
Domain	TENEURIN_N	TENM2 TENM4	1.62e-04	4	98	2	PS51361
Domain	Biotin_BS	ACACB PCCA	2.70e-04	5	98	2	IPR001882
Domain	Biotin_COase_C	ACACB PCCA	2.70e-04	5	98	2	IPR005482
Domain	YD	TENM2 TENM4	2.70e-04	5	98	2	IPR006530
Domain	BC	ACACB PCCA	2.70e-04	5	98	2	PS50979
Domain	Biotin_carb_C	ACACB PCCA	2.70e-04	5	98	2	SM00878
Domain	Biotin_carb_C	ACACB PCCA	2.70e-04	5	98	2	PF02785
Domain	Biotin_carboxylation_dom	ACACB PCCA	2.70e-04	5	98	2	IPR011764
Domain	BIOTIN	ACACB PCCA	2.70e-04	5	98	2	PS00188
Domain	RIH_assoc-dom	RYR2 RYR3	4.03e-04	6	98	2	IPR013662
Domain	Ins145_P3_rec	RYR2 RYR3	4.03e-04	6	98	2	PF08709
Domain	Rudment_hybrid_motif	ACACB PCCA	4.03e-04	6	98	2	IPR011054
Domain	RIH_assoc	RYR2 RYR3	4.03e-04	6	98	2	PF08454
Domain	RIH_dom	RYR2 RYR3	4.03e-04	6	98	2	IPR000699
Domain	Ins145_P3_rcpt	RYR2 RYR3	4.03e-04	6	98	2	IPR014821
Domain	Ryanodine_recept-rel	RYR2 RYR3	4.03e-04	6	98	2	IPR015925
Domain	-	RYR2 RYR3	4.03e-04	6	98	2	1.25.10.30
Domain	RYDR_ITPR	RYR2 RYR3	4.03e-04	6	98	2	PF01365
Domain	HEAT_REPEAT	RELCH BTAF1 NCAPG PRKDC	5.01e-04	70	98	4	PS50077
Domain	Clathrin	CLTCL1 CLTC	5.63e-04	7	98	2	PF00637
Domain	CHCR	CLTCL1 CLTC	5.63e-04	7	98	2	PS50236
Domain	ATP_grasp_subdomain_2	ACACB CPS1 PCCA	5.66e-04	31	98	3	IPR013816
Domain	Clathrin_H-chain/VPS_repeat	CLTCL1 CLTC	7.48e-04	8	98	2	IPR000547
Domain	RBM1CTR	RBMXL2 RBMX	7.48e-04	8	98	2	PF08081
Domain	RBM1CTR	RBMXL2 RBMX	7.48e-04	8	98	2	IPR012604
Domain	Biotin_lipoyl	ACACB PCCA	9.58e-04	9	98	2	PF00364
Domain	MIR	RYR2 RYR3	1.19e-03	10	98	2	PF02815
Domain	MIR_motif	RYR2 RYR3	1.19e-03	10	98	2	IPR016093
Domain	BIOTINYL_LIPOYL	ACACB PCCA	1.19e-03	10	98	2	PS50968
Domain	MIR	RYR2 RYR3	1.19e-03	10	98	2	PS50919
Domain	MIR	RYR2 RYR3	1.19e-03	10	98	2	SM00472
Domain	Biotin_lipoyl	ACACB PCCA	1.19e-03	10	98	2	IPR000089
Domain	EF_HAND_2	VSNL1 LCP1 RYR2 RYR3 EFHC2 DST	1.37e-03	231	98	6	PS50222
Domain	EF_hand_dom	VSNL1 LCP1 RYR2 RYR3 EFHC2 DST	1.40e-03	232	98	6	IPR002048
Domain	TPR-like_helical_dom	CLTCL1 TTC6 CLTC CSTF3 PRKDC CABIN1	1.43e-03	233	98	6	IPR011990
Domain	P-loop_NTPase	ABCC1 ABCF1 MYO10 PSMC2 RNF213 BTAF1 DLG4 ASCC3 DDX24 DNAH6 DYNC1H1 CNP	1.59e-03	848	98	12	IPR027417
Domain	Single_hybrid_motif	ACACB PCCA	1.74e-03	12	98	2	IPR011053
Domain	-	ABCC1 ABCF1 PSMC2 RNF213 BTAF1 DLG4 ASCC3 DDX24 DNAH6 DYNC1H1 CNP	1.82e-03	746	98	11	3.40.50.300
Domain	HEAT	BTAF1 NCAPG PRKDC	2.04e-03	48	98	3	PF02985
Domain	NHL	TENM2 TENM4	2.05e-03	13	98	2	PS51125
Domain	Dynein_heavy_chain_D4_dom	DNAH6 DYNC1H1	2.38e-03	14	98	2	IPR024317
Domain	Dynein_HC_stalk	DNAH6 DYNC1H1	2.38e-03	14	98	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH6 DYNC1H1	2.38e-03	14	98	2	IPR013602
Domain	DHC_N2	DNAH6 DYNC1H1	2.38e-03	14	98	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH6 DYNC1H1	2.38e-03	14	98	2	IPR011704
Domain	MT	DNAH6 DYNC1H1	2.38e-03	14	98	2	PF12777
Domain	AAA_8	DNAH6 DYNC1H1	2.38e-03	14	98	2	PF12780
Domain	AAA_5	DNAH6 DYNC1H1	2.38e-03	14	98	2	PF07728
Domain	-	VSNL1 LCP1 RYR2 RYR3 EFHC2 DST	2.53e-03	261	98	6	1.10.238.10
Domain	DHC_fam	DNAH6 DYNC1H1	2.74e-03	15	98	2	IPR026983
Domain	Dynein_heavy	DNAH6 DYNC1H1	2.74e-03	15	98	2	PF03028
Domain	Dynein_heavy_dom	DNAH6 DYNC1H1	2.74e-03	15	98	2	IPR004273
Domain	ARM-like	RELCH FRYL BTAF1 PPP4R3A NCAPG PRKDC	3.00e-03	270	98	6	IPR011989
Domain	HEAT	BTAF1 NCAPG PRKDC	3.51e-03	58	98	3	IPR000357
Domain	CarboxyPept-like_regulatory	TENM2 TENM4	3.52e-03	17	98	2	IPR008969
Domain	HATPase_c	TOP2A HSP90AA1	3.95e-03	18	98	2	SM00387
Domain	EF-hand-dom_pair	VSNL1 LCP1 RYR2 RYR3 EFHC2 DST	4.04e-03	287	98	6	IPR011992
Domain	HATPase_c	TOP2A HSP90AA1	4.40e-03	19	98	2	PF02518
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	RBM15 ABCF1 PSMC2 FRYL LCP1 DIS3 DST RBMX NUP210 CLTC KMT2A PRKDC ASCC3 DDX24 IMMT DYNC1H1	7.27e-11	653	101	16	22586326
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	ABCC1 CLTCL1 PSMC2 RNF213 BTAF1 DIS3 NCAPG DST AASS NUP210 EIF2B2 CLTC KMT2A PRKDC CTNNA2 ASCC3 CABIN1 DDX24 TOP2A DYNC1H1 CNP HSP90AA1	1.31e-10	1440	101	22	30833792
Pubmed	Defining the membrane proteome of NK cells.	ABCC1 ABCF1 CLTCL1 IARS1 PSMC2 RNF213 DIS3 NCAPG GLE1 NUP210 CLTC IQSEC1 PRKDC PLD1 ASCC3 DDX24 IMMT DYNC1H1 CNP HSP90AA1	1.44e-10	1168	101	20	19946888
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	IARS1 PSMC2 DIS3 PPP4R3A NCAPG RBMX NUP210 CLTC CSTF3 PRKDC ASCC3 IMMT DYNC1H1 CNP HSP90AA1	5.29e-10	638	101	15	33239621
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	RBM15 ABCF1 ACACB IARS1 PSMC2 LCP1 DIS3 BAP1 NCAPG RBMX CLTC IQSEC1 KMT2A PRKDC ASCC3 DDX24 PCCA TOP2A DYNC1H1 HSP90AA1	1.16e-09	1318	101	20	30463901
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ABCC1 RELCH RBM15 EYA4 PSMC2 EXOC3 RNF213 PFDN2 EYA2 PPP4R3A PTPN11 NCAPG TBC1D31 CD2BP2 NUP210 CLTC CSTF3 HSP90AA1	1.30e-09	1049	101	18	27880917
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	ABCF1 IARS1 EXOC3 RNF213 DIS3 NCAPG RBMX CLTC KMT2A PRKDC ASCC3 TOP2A DYNC1H1 CNP	2.35e-09	601	101	14	33658012
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	ABCF1 IARS1 PSMC2 PFDN2 CPS1 CCDC51 DIS3 PTPN11 NCAPG TXNL4A RBMX CD2BP2 CLTC PRKDC DDX24 IMMT TOP2A DYNC1H1 CNP HSP90AA1	3.90e-09	1415	101	20	28515276
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	RBM15 ABCF1 IARS1 EXOC3 BTAF1 DST GLE1 RBMX NUP210 CLTC CSTF3 PRKDC ASCC3 IMMT TOP2A DYNC1H1 CNP	6.46e-09	1024	101	17	24711643
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RBM15 ABCF1 BTAF1 EZH2 PPP4R3A BAP1 KANSL2 RBMXL2 RBMX CLTC IQSEC1 KMT2A PRKDC DDX24 TOP2A	7.19e-09	774	101	15	15302935
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RBM15 ABCF1 IARS1 PSMC2 EXOC3 DIS3 NCAPG DST RBMX CLTC IQSEC1 PRKDC ASCC3 DDX24 IMMT TOP2A DYNC1H1 CNP HSP90AA1	1.12e-08	1353	101	19	29467282
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	ABCF1 IARS1 RNF213 FRYL DIS3 NLN PTPN11 NCAPG RBMX CLTC CSTF3 PRKDC DDX24 PCCA IMMT TOP2A CNP HSP90AA1 RAD23A	1.32e-08	1367	101	19	32687490
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	CLTCL1 IARS1 PSMC2 PFDN2 LCP1 PPP4R3A NEDD4 HARS2 NCAPG CLTC PRKDC DNAH6 IMMT DYNC1H1 HSP90AA1	2.37e-08	847	101	15	35235311
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	RELCH IARS1 PSMC2 PFDN2 HARS2 CLTC PRKDC CIAO2A DDX24 DYNC1H1 HSP90AA1	2.49e-08	399	101	11	37536630
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	EYA4 CMTR1 IARS1 BTAF1 CPS1 BAP1 KANSL2 NCAPG RBMX KDM1B CABIN1 DDX24 TOP2A DYNC1H1 HSP90AA1	2.76e-08	857	101	15	25609649
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	RBM15 MYO10 IARS1 PSMC2 PFDN2 CERT1 DIS3 BAP1 TXNL4A RBMX CD2BP2 KDM1B ASCC3 DDX24 IMMT RAD23A	3.37e-08	1005	101	16	19615732
Pubmed	Mechanisms and Consequences of Dopamine Depletion-Induced Attenuation of the Spinophilin/Neurofilament Medium Interaction.	RELCH RBMX CLTC IQSEC1 DLG4 CTNNA2 CNP	1.17e-07	131	101	7	28634551
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	RBM15 ABCF1 IARS1 HARS2 DST RBMX CD2BP2 NUP210 CLTC PRKDC ASCC3 DDX24 IMMT TOP2A DYNC1H1 CNP HSP90AA1	1.25e-07	1257	101	17	36526897
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	RBM15 DDX12P IARS1 PSMC2 BTAF1 DIS3 AASS RBMX CD2BP2 NUP210 CLTC PRKDC ASCC3 IMMT DYNC1H1 CNP HSP90AA1	1.25e-07	1257	101	17	37317656
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	CLTCL1 IARS1 NUP210 CLTC KMT2A PRKDC ASCC3 IMMT	1.43e-07	202	101	8	24639526
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	CNNM2 EYA4 PSMC2 EYA2 LCP1 DIS3 PPP4R3A PTPN11 RBMX NUP210 DLG4 PRKDC ASCC3 IMMT CNP	1.45e-07	974	101	15	28675297
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	RBM15 SHROOM3 IARS1 DIS3 DST RBMX NUP210 CLTC PRKDC DYNC1H1 HSP90AA1	1.51e-07	477	101	11	31300519
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	ABCC1 RBM15 SLC25A20 ABCF1 IARS1 PSMC2 RBMX CLTC KMT2A PRKDC IMMT DYNC1H1 CNP	1.53e-07	711	101	13	33022573
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	RBM15 IARS1 CPS1 RBMX CD2BP2 NUP210 C1D CSTF3 KMT2A PRKDC PLD1 DDX24 TOP2A HSP90AA1	1.68e-07	847	101	14	35850772
Pubmed	MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer.	PFDN2 BAP1 RBMX CLTC PRKDC KDM1B TOP2A CNP HSP90AA1	1.68e-07	287	101	9	36180891
Pubmed	AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.	ABCC1 IARS1 PTPN11 NCAPG CLTC ASCC3 PCCA IMMT TOP2A DYNC1H1 HSP90AA1	1.75e-07	484	101	11	31995728
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	RELCH ABCF1 ACACB IARS1 ANKS1B PSMC2 TENM2 RYR2 TENM4 CLTC IQSEC1 DLG4 TACC1 CTNNA2 PCCA HSP90AA1	1.85e-07	1139	101	16	36417873
Pubmed	Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis.	PSMC2 RNF213 CPS1 CLTC PRKDC DYNC1H1 HSP90AA1	2.24e-07	144	101	7	35681168
Pubmed	Deltex3 inhibits Epithelial Mesenchymal Transition in Papillary Thyroid Carcinoma via promoting ubiquitination of XRCC5 to regulate the AKT signal pathway.	RBMX CLTC PRKDC IMMT HSP90AA1	2.33e-07	46	101	5	33403043
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	RBM15 RNF213 DIS3 PPP4R3A PTPN11 NCAPG CD2BP2 CSTF3 KMT2A PRKDC KDM1B IMMT TOP2A HSP90AA1 RAD23A	2.42e-07	1014	101	15	32416067
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	ABCC1 RBM15 SHROOM3 SLC25A20 IARS1 PSMC2 DIS3 PTPN11 NCAPG CLTC PRKDC IMMT DYNC1H1 HSP90AA1	2.59e-07	878	101	14	37223481
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	RBM15 CMTR1 LCP1 PTPN11 NCAPG DST TBC1D31 KMT2A KDM1B CABIN1 CNP RAD23A	3.97e-07	645	101	12	25281560
Pubmed	The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs.	IARS1 PSMC2 NCAPG NUP210 EIF2B2 CLTC PRKDC IMMT HSP90AA1	4.20e-07	320	101	9	28685749
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ABCF1 ACACB PSMC2 BTAF1 DIS3 PPP4R3A PTPN11 DST KMT2A TACC1 PRKDC PCCA TOP2A HSP90AA1	5.42e-07	934	101	14	33916271
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	MYO10 IARS1 DST CLTC TACC1 PRKDC TOP2A DYNC1H1 HSP90AA1	5.71e-07	332	101	9	37433992
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	ABCF1 IARS1 RNF213 NCAPG CLTC PRKDC TOP2A DYNC1H1 HSP90AA1	5.71e-07	332	101	9	32786267
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	ABCC1 IARS1 PSMC2 BTAF1 NCAPG GLE1 NUP210 EIF2B2 CLTC CSTF3 PRKDC ASCC3 IMMT DYNC1H1	6.00e-07	942	101	14	31073040
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	RBM15 ABCF1 IARS1 PSMC2 FRYL DIS3 RBMX CLTC PRKDC CNP HSP90AA1	6.28e-07	551	101	11	34728620
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	RBM15 ABCF1 IARS1 PSMC2 RBMX CD2BP2 CLTC PRKDC TOP2A HSP90AA1	6.67e-07	441	101	10	31239290
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	PSMC2 EXOC3 PPP4R3A NCAPG CD2BP2 CLTC CSTF3 DDX24 IMMT TOP2A DYNC1H1	7.36e-07	560	101	11	35241646
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ABCF1 IARS1 RBP3 ANKS1B TENM4 DST RBMX CLTC IQSEC1 KMT2A DLG4 CTNNA2 DNAH6 IMMT DYNC1H1 CNP HSP90AA1	7.66e-07	1431	101	17	37142655
Pubmed	RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes.	IARS1 RNF213 CLTC KMT2A PRKDC PCCA DYNC1H1 CNP HSP90AA1	7.67e-07	344	101	9	36282215
Pubmed	DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization.	IARS1 PSMC2 PRKDC IMMT DYNC1H1 CNP HSP90AA1	8.36e-07	175	101	7	25756610
Pubmed	Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants.	IARS1 PFDN2 CPS1 PRKDC IMMT DYNC1H1 CNP HSP90AA1	8.65e-07	256	101	8	35777956
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	VSNL1 ABCF1 ANKS1B PFDN2 RYR3 CREBZF KANSL2 DST CLTC DLG4 MIGA1 PRKDC CABIN1 IMMT DYNC1H1 HSP90AA1	9.15e-07	1285	101	16	35914814
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	LCP1 DIS3 TXNL4A RBMX NUP210 EIF2B2 CLTC CSTF3 ASCC3 IMMT TOP2A HSP90AA1	9.51e-07	701	101	12	30196744
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ABCC1 RBM15 EYA4 EZH2 BAP1 KANSL2 DST RBMX CD2BP2 KMT2A PRKDC KDM1B CABIN1 DDX24 PCCA TOP2A	1.00e-06	1294	101	16	30804502
Pubmed	Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.	ABCF1 IARS1 LCP1 PTPN11 RBMX NUP210 CLTC PRKDC IMMT TOP2A DYNC1H1 HSP90AA1	1.04e-06	707	101	12	19738201
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	CMTR1 ACACB PTPN11 CLTC PRKDC ASCC3 PCCA DYNC1H1 HSP90AA1	1.04e-06	357	101	9	37059091
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	ABCF1 RNF213 PFDN2 RBMXL2 DST RBMX CLTC PRKDC CTNNA2 TOP2A DYNC1H1 CNP HSP90AA1	1.06e-06	844	101	13	25963833
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	RBM15 SHROOM3 PSMC2 BTAF1 NCAPG RBMX CSTF3 PRKDC TOP2A DYNC1H1 HSP90AA1	1.07e-06	582	101	11	20467437
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	RBM15 IARS1 BTAF1 DST RBMX CD2BP2 PRKDC DYNC1H1 HSP90AA1	1.12e-06	360	101	9	33111431
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	CLTCL1 IARS1 PSMC2 PFDN2 LCP1 NCAPG RBMXL2 RBMX CD2BP2 NUP210 CLTC PRKDC IMMT DYNC1H1 HSP90AA1	1.21e-06	1153	101	15	29845934
Pubmed	ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.	IARS1 RNF213 CLTC PRKDC ASCC3 IMMT DYNC1H1 HSP90AA1	1.22e-06	268	101	8	33024031
Pubmed	Genomic analysis of mouse retinal development.	CDR2 RBP3 FRYL EYA2 CREBZF PPP4R3A NEDD4 KANSL2 DST KMT2A DLG4 PRKDC PCCA HSP90AA1	1.30e-06	1006	101	14	15226823
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	RELCH CDR2 EYA4 ABCF1 IARS1 EXOC3 CCDC51 DIS3 PPP4R3A EFHC2 CD2BP2 EIF2B2 DDX24 IMMT DYNC1H1 CNP	1.31e-06	1321	101	16	27173435
Pubmed	Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95.	PSMC2 DLG4 RAD23A	1.32e-06	8	101	3	23260144
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	ABCF1 IARS1 PSMC2 EXOC3 PFDN2 TTC6 NCAPG RBMX EIF2B2 CLTC CSTF3 PRKDC ASCC3 DDX24 IMMT HSP90AA1	1.50e-06	1335	101	16	29229926
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	RBM15 ABCF1 IARS1 RBMX CD2BP2 KMT2A PRKDC ASCC3 DDX24 TOP2A HSP90AA1	1.56e-06	605	101	11	28977666
Pubmed	Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.	SHROOM3 CLTCL1 CCDC51 RYR2 RYR3 PRKDC HSP90AA1	1.72e-06	195	101	7	17110338
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	RBM15 ABCF1 ACACB EXOC3 LCP1 TTC6 RYR3 KMT2A ASCC3 DDX24	1.95e-06	497	101	10	36774506
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	RBM15 VSNL1 PFDN2 SHC3 HARS2 RBMX CD2BP2 CLTC IQSEC1 C1D KMT2A CTNNA2 PLD1 ASCC3 DYNC1H1 CNP	2.12e-06	1371	101	16	36244648
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	IARS1 EXOC3 EZH2 NCAPG TXNL4A KMT2A PRKDC DDX24 TOP2A	2.34e-06	394	101	9	27248496
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	RBM15 IARS1 PSMC2 DIS3 NCAPG RBMX CLTC PRKDC IMMT TOP2A HSP90AA1	2.71e-06	641	101	11	36057605
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SHROOM3 ACACB RNF213 RYR2 DST CLTC TACC1 PRKDC PLD1 PCCA DYNC1H1 HSP90AA1	2.75e-06	777	101	12	35844135
Pubmed	Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization.	PRKDC DYNC1H1 HSP90AA1	2.81e-06	10	101	3	19826009
Pubmed	Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry.	RBMX PRKDC TOP2A DYNC1H1	2.91e-06	34	101	4	11101529
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	PSMC2 RNF213 RBMX PRKDC DYNC1H1	2.93e-06	76	101	5	27542412
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	RBM15 ABCF1 IARS1 PSMC2 PFDN2 DIS3 RBMX CLTC PRKDC ASCC3 DDX24 IMMT TOP2A DYNC1H1 HSP90AA1	3.17e-06	1247	101	15	27684187
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	RBM15 ABCF1 GJC1 DST RBMX CLTC CSTF3 PRKDC IMMT TOP2A CNP	3.59e-06	660	101	11	32780723
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	RBM15 ABCF1 IARS1 PFDN2 LCP1 PPP4R3A RBMX CLTC CSTF3 KMT2A PRKDC TOP2A DYNC1H1 RAD23A	3.78e-06	1103	101	14	34189442
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	RBM15 ABCF1 MYO10 IARS1 CPS1 SHC3 DST RBMX CLTC PRKDC TOP2A DYNC1H1 HSP90AA1	3.82e-06	949	101	13	36574265
Pubmed	Guanylate binding protein 1-mediated interaction of T cell antigen receptor signaling with the cytoskeleton.	IARS1 LCP1 HSP90AA1	3.86e-06	11	101	3	24337748
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	MYO10 IARS1 PSMC2 PFDN2 DST CLTC PCCA TOP2A DYNC1H1 HSP90AA1	3.94e-06	538	101	10	28524877
Pubmed	GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system.	IARS1 CLTC PRKDC IMMT TOP2A DYNC1H1 HSP90AA1	3.94e-06	221	101	7	29991511
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CLTCL1 ACACB ANKS1B LCP1 RYR2 RBMXL2 DST TBC1D31 RBMX CLTC KMT2A PRKDC DNAH6 IMMT TOP2A HSP90AA1	4.04e-06	1442	101	16	35575683
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	RBM15 ABCF1 HARS2 RBMX CLTC CSTF3 PRKDC ASCC3 DDX24 TOP2A DYNC1H1 HSP90AA1	4.05e-06	807	101	12	22681889
Pubmed	RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.	ABCF1 CMTR1 IARS1 CPS1 RBMX CLTC PRKDC DYNC1H1 HSP90AA1	4.33e-06	425	101	9	21081503
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SHROOM3 ANKS1B TENM2 NEDD4 DST CLTC IQSEC1 DLG4 CTNNA2 CABIN1 DYNC1H1 CNP HSP90AA1	4.47e-06	963	101	13	28671696
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	RELCH ABCF1 IARS1 PSMC2 PFDN2 FRYL CERT1 DIS3 PPP4R3A PTPN11 NCAPG EIF2B2 PRKDC DYNC1H1 HSP90AA1 RAD23A	4.52e-06	1455	101	16	22863883
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	PSMC2 PTPN11 NCAPG CLTC KMT2A PRKDC ASCC3 PCCA TOP2A DYNC1H1	4.70e-06	549	101	10	38280479
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	RBM15 ABCF1 MYO10 GJC1 PSMC2 PFDN2 BTAF1 RBMX CD2BP2 CSTF3 CTNNA2 DDX24 HSP90AA1	4.89e-06	971	101	13	33306668
Pubmed	Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation.	IARS1 PSMC2 RBMX CLTC	5.65e-06	40	101	4	16210410
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	RBM15 ACACB FAT3 DST CLTC DDX24 TOP2A	5.74e-06	234	101	7	36243803
Pubmed	Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations.	MYO10 CPS1 DIS3 CLTC PRKDC CTNNA2 DYNC1H1	5.90e-06	235	101	7	28378594
Pubmed	USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease.	IARS1 PSMC2 CPS1 DIS3 PRKDC DDX24 IMMT DYNC1H1 CNP HSP90AA1	6.05e-06	565	101	10	33567341
Pubmed	NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90.	CPS1 TTC6 RBMX CLTC CSTF3 PRKDC DYNC1H1 HSP90AA1	6.06e-06	333	101	8	32665550
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	CNNM2 CLTCL1 ACACB PSMC2 PFDN2 EYA2 PPP4R3A PRKDC DYNC1H1 HSP90AA1	6.84e-06	573	101	10	28330616
Pubmed	Proteomic identification of brain proteins that interact with dynein light chain LC8.	SHROOM3 MYO10 DLG4 DYNC1H1	6.89e-06	42	101	4	14760703
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	IARS1 PSMC2 EXOC3 PTPN11 DST PRKDC ASCC3 IMMT DYNC1H1 CNP HSP90AA1	6.96e-06	708	101	11	39231216
Pubmed	Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.	GLE1 RBMX NUP210 CSTF3 PRKDC ASCC3 TOP2A DYNC1H1	7.05e-06	340	101	8	29478914
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	SHROOM3 ABCF1 ACACB PSMC2 PFDN2 LCP1 TBC1D31 AASS PCCA TOP2A DYNC1H1 HSP90AA1	7.09e-06	853	101	12	28718761
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	IARS1 CPS1 LCP1 PTPN11 NCAPG CLTC PRKDC DYNC1H1	7.68e-06	344	101	8	30333137
Pubmed	Spatial Chromosome Folding and Active Transcription Drive DNA Fragility and Formation of Oncogenic MLL Translocations.	KMT2A TOP2A	8.35e-06	2	101	2	31202576
Pubmed	RBM15-Mediated N6-Methyl Adenosine (m6A) Modification of EZH2 Drives the Epithelial-Mesenchymal Transition of Cervical Cancer.	RBM15 EZH2	8.35e-06	2	101	2	38842201
Pubmed	The evolutionarily conserved Dim1 protein defines a novel branch of the thioredoxin fold superfamily.	TXNL4A TXNL4B	8.35e-06	2	101	2	11015569
Pubmed	Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia.	FRYL KMT2A	8.35e-06	2	101	2	17854671
Pubmed	TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup.	EZH2 TOP2A	8.35e-06	2	101	2	28899973
Pubmed	DNA-PK-mediated phosphorylation of EZH2 regulates the DNA damage-induced apoptosis to maintain T-cell genomic integrity.	EZH2 PRKDC	8.35e-06	2	101	2	27468692
Pubmed	Tissue-specific alternative splicing of mouse brain type ryanodine receptor/calcium release channel mRNA.	RYR2 RYR3	8.35e-06	2	101	2	8898078
Interaction	SIRT7 interactions	RBM15 ABCF1 PSMC2 FRYL LCP1 DIS3 DST RBMX NUP210 CLTC KMT2A PRKDC ASCC3 DDX24 IMMT TOP2A DYNC1H1	1.19e-07	744	99	17	int:SIRT7
Interaction	EPHA1 interactions	RELCH BTAF1 PTPN11 DST EIF2B2 MIGA1 PRKDC DDX24 DYNC1H1 HSP90AA1	2.41e-07	235	99	10	int:EPHA1
Interaction	FBXW7 interactions	CDR2 ABCF1 IARS1 EXOC3 RNF213 EZH2 DIS3 PTPN11 NCAPG TXNL4A TXNL4B RBMX CLTC KMT2A PRKDC ASCC3 DDX24 TOP2A DYNC1H1 CNP HSP90AA1	3.59e-07	1215	99	21	int:FBXW7
Interaction	EXOSC3 interactions	CLTCL1 EZH2 CERT1 DIS3 BAP1 C1D DDX24	6.14e-07	100	99	7	int:EXOSC3
Interaction	PRPF8 interactions	ABCF1 CMTR1 IARS1 PFDN2 CPS1 ASB15 EZH2 BAP1 NEDD4 TXNL4A CD2BP2 CLTC PRKDC TOP2A DYNC1H1 HSP90AA1	1.14e-06	776	99	16	int:PRPF8
Interaction	WDR5 interactions	ABCC1 RBM15 SLC25A20 ABCF1 ACACB IARS1 PSMC2 BAP1 KANSL2 RBMX CLTC IQSEC1 KMT2A PRKDC KDM1B IMMT DYNC1H1 CNP HSP90AA1	1.46e-06	1101	99	19	int:WDR5
Interaction	PTGES3 interactions	ABCC1 CMTR1 PFDN2 EYA2 BAP1 FIG4 PRKDC PLD1 KDM1B ASCC3 TOP2A HSP90AA1	1.56e-06	437	99	12	int:PTGES3
Interaction	STIP1 interactions	IARS1 PSMC2 EZH2 DIS3 PPP4R3A BAP1 PTPN11 NCAPG RBMX NUP210 CLTC CSTF3 PRKDC ASCC3 IMMT DYNC1H1 CNP HSP90AA1	1.73e-06	1006	99	18	int:STIP1
Interaction	MOB3C interactions	RELCH IARS1 PSMC2 PFDN2 HARS2 CLTC PRKDC CIAO2A DDX24 DYNC1H1 HSP90AA1	1.75e-06	364	99	11	int:MOB3C
Interaction	GRIN2B interactions	EXOC3 SHC3 RYR2 PTPN11 TENM4 CLTC DLG4 CTNNA2	1.94e-06	170	99	8	int:GRIN2B
Interaction	SNCA interactions	ABCF1 IARS1 PFDN2 DIS3 PPP4R3A NEDD4 NCAPG DST CD2BP2 CLTC PLD1 TOP2A DYNC1H1 CNP HSP90AA1	2.11e-06	716	99	15	int:SNCA
Interaction	PRPF19 interactions	CMTR1 EXOC3 EZH2 BAP1 PTPN11 GLE1 RBMX CD2BP2 PRKDC TOP2A DYNC1H1 HSP90AA1	2.12e-06	450	99	12	int:PRPF19
Interaction	MEN1 interactions	RBM15 CMTR1 IARS1 RNF213 BTAF1 EZH2 DIS3 KANSL2 RBMX CD2BP2 NUP210 C1D CSTF3 KMT2A DDX24 TOP2A HSP90AA1 RAD23A	2.39e-06	1029	99	18	int:MEN1
Interaction	BRCA2 interactions	RELCH EYA4 BAP1 NEDD4 FIG4 RBMX KMT2A TOP2A DYNC1H1 HSP90AA1 RAD23A	2.93e-06	384	99	11	int:BRCA2
Interaction	CCDC8 interactions	ABCF1 IARS1 EXOC3 BTAF1 DST GLE1 RBMX CLTC PRKDC ASCC3 IMMT TOP2A DYNC1H1 CNP	3.86e-06	656	99	14	int:CCDC8
Interaction	STK32C interactions	NUP210 IQSEC1 PRKDC DYNC1H1 CNP HSP90AA1	4.42e-06	87	99	6	int:STK32C
Interaction	KCNA3 interactions	CMTR1 IARS1 PSMC2 EXOC3 RNF213 SHC3 PTPN11 DST KMT2A DLG4 PRKDC ASCC3 IMMT DYNC1H1 CNP HSP90AA1	5.05e-06	871	99	16	int:KCNA3
Interaction	RPS6KL1 interactions	NUP210 PRKDC DYNC1H1 CNP HSP90AA1	5.07e-06	51	99	5	int:RPS6KL1
Interaction	AATK interactions	RELCH EYA4 EYA2 PTPN11 PRKDC DYNC1H1 CNP HSP90AA1	5.17e-06	194	99	8	int:AATK
Interaction	ISG15 interactions	IARS1 RNF213 EZH2 NEDD4 CLTC PRKDC ASCC3 IMMT TOP2A DYNC1H1 HSP90AA1 RAD23A	5.51e-06	494	99	12	int:ISG15
Interaction	LGR4 interactions	CLTCL1 IARS1 NEDD4 NUP210 CLTC KMT2A PRKDC ASCC3 IMMT	5.78e-06	262	99	9	int:LGR4
Interaction	EFTUD2 interactions	ABCF1 IARS1 PFDN2 CPS1 EZH2 CCDC51 DIS3 BAP1 PTPN11 NCAPG TXNL4A RBMX CD2BP2 CLTC PRKDC DDX24 IMMT TOP2A DYNC1H1 CNP HSP90AA1	5.99e-06	1449	99	21	int:EFTUD2
Interaction	SNRPD2 interactions	PSMC2 RNF213 EZH2 PPP4R3A BAP1 TXNL4A RBMX CD2BP2 PRKDC TOP2A DYNC1H1	6.00e-06	414	99	11	int:SNRPD2
Interaction	GRK7 interactions	ACACB NEDD4 TOP2A HSP90AA1	6.40e-06	25	99	4	int:GRK7
Interaction	OCIAD1 interactions	CLTCL1 EXOC3 RNF213 BTAF1 PPP4R3A NCAPG GLE1 MIGA1 TACC1 DDX24 IMMT	6.72e-06	419	99	11	int:OCIAD1
Interaction	FLT4 interactions	IARS1 SHC3 NEDD4 PTPN11 TACC1 PRKDC DYNC1H1 CNP HSP90AA1	7.81e-06	272	99	9	int:FLT4
Interaction	YWHAB interactions	CDR2 SHROOM3 PFDN2 FRYL EZH2 BAP1 NEDD4 PTPN11 DST AASS RBMX CLTC KMT2A DLG4 DDX24 DYNC1H1 HSP90AA1	8.29e-06	1014	99	17	int:YWHAB
Interaction	MAGEA9 interactions	PSMC2 EXOC3 BTAF1 IQSEC1 MIGA1 PLD1 DDX24 TOP2A	8.62e-06	208	99	8	int:MAGEA9
Interaction	ASXL2 interactions	PFDN2 EZH2 BAP1 RBMX CLTC PRKDC KDM1B CNP HSP90AA1	9.04e-06	277	99	9	int:ASXL2
Interaction	YWHAE interactions	CDR2 RBM15 SHROOM3 PFDN2 FRYL EZH2 BAP1 GSTA1 NEDD4 DST AASS CLTC KMT2A DLG4 DDX24 TOP2A DYNC1H1 HSP90AA1 RAD23A	9.88e-06	1256	99	19	int:YWHAE
Interaction	RYK interactions	CNNM2 FAT3 PTPN11 DST PRKDC CTNNA2 PLD1 DYNC1H1	9.91e-06	212	99	8	int:RYK
Interaction	CPSF6 interactions	RBM15 EYA4 CMTR1 PFDN2 EZH2 PPP4R3A BAP1 NEDD4 TXNL4A RBMX CLTC CSTF3	1.04e-05	526	99	12	int:CPSF6
Interaction	MCC interactions	IARS1 ANKS1B EXOC3 KANSL2 CLTC PLD1 PCCA HSP90AA1	1.10e-05	215	99	8	int:MCC
Interaction	EP300 interactions	RBM15 EYA4 ABCF1 CLTCL1 CMTR1 PSMC2 EXOC3 BTAF1 EZH2 DIS3 NEDD4 TXNL4A RBMX CLTC CSTF3 PRKDC DDX24 IMMT TOP2A RAD23A	1.30e-05	1401	99	20	int:EP300
Interaction	NR2C2 interactions	RBM15 ABCF1 ACACB IARS1 PSMC2 LCP1 DIS3 BAP1 NCAPG RBMX CLTC IQSEC1 KMT2A PRKDC ASCC3 DDX24 PCCA TOP2A DYNC1H1 HSP90AA1	1.33e-05	1403	99	20	int:NR2C2
Interaction	AXL interactions	RBM15 IARS1 SHC3 DIS3 PTPN11 PRKDC IMMT DYNC1H1 CNP HSP90AA1	1.38e-05	369	99	10	int:AXL
Interaction	SNW1 interactions	RBM15 SHROOM3 PSMC2 EXOC3 BTAF1 EZH2 NCAPG TXNL4A RBMX CD2BP2 CSTF3 KMT2A PRKDC HSP90AA1	1.68e-05	747	99	14	int:SNW1
Interaction	SERBP1 interactions	ABCC1 RBM15 SHROOM3 SLC25A20 CMTR1 IARS1 PSMC2 DIS3 BAP1 HARS2 PTPN11 NCAPG CLTC CSTF3 PRKDC DDX24 IMMT TOP2A DYNC1H1 HSP90AA1	1.79e-05	1432	99	20	int:SERBP1
Interaction	IGF1R interactions	RNF213 EZH2 BAP1 NEDD4 PTPN11 NUP210 CLTC TACC1 PRKDC CNP HSP90AA1	1.85e-05	467	99	11	int:IGF1R
Interaction	MCM2 interactions	RELCH ABCF1 RNF213 PFDN2 EZH2 PPP4R3A BAP1 DST RBMX CLTC KMT2A PRKDC CTNNA2 CABIN1 DYNC1H1 CNP HSP90AA1	1.90e-05	1081	99	17	int:MCM2
Interaction	EED interactions	RBM15 SHROOM3 ABCF1 ACACB IARS1 PSMC2 EZH2 DIS3 NEDD4 TBC1D31 RBMX NUP210 CLTC PRKDC ASCC3 DDX24 IMMT TOP2A DYNC1H1 HSP90AA1	2.04e-05	1445	99	20	int:EED
Interaction	CIT interactions	RBM15 ABCF1 CLTCL1 IARS1 RNF213 CPS1 EZH2 NLN RBMXL2 RBMX NUP210 CLTC CSTF3 KMT2A DLG4 PRKDC IMMT TOP2A DYNC1H1 HSP90AA1	2.14e-05	1450	99	20	int:CIT
Interaction	RUFY1 interactions	IARS1 RNF213 CERT1 NLN CLTC KMT2A PRKDC PCCA DYNC1H1 CNP HSP90AA1	2.21e-05	476	99	11	int:RUFY1
Interaction	GRWD1 interactions	ACACB IARS1 CLTC KMT2A PRKDC DDX24 IMMT TOP2A DYNC1H1 HSP90AA1	2.21e-05	390	99	10	int:GRWD1
Interaction	SF3B1 interactions	RBM15 CMTR1 EZH2 CERT1 PPP4R3A BAP1 TXNL4A RBMX CD2BP2 PRKDC TOP2A DYNC1H1	2.34e-05	571	99	12	int:SF3B1
Interaction	SLX4 interactions	RBM15 CMTR1 ACACB PTPN11 RBMX CLTC IQSEC1 PRKDC ASCC3 PCCA DYNC1H1 HSP90AA1	2.38e-05	572	99	12	int:SLX4
Interaction	FLT3 interactions	IARS1 RNF213 PTPN11 NUP210 KMT2A PRKDC DYNC1H1 CNP HSP90AA1	2.70e-05	318	99	9	int:FLT3
Interaction	FLT1 interactions	IARS1 RNF213 NEDD4 PTPN11 PRKDC DYNC1H1 CNP	2.90e-05	179	99	7	int:FLT1
Interaction	YWHAQ interactions	CDR2 SHROOM3 PFDN2 FRYL CPS1 EZH2 BAP1 NEDD4 DST AASS CLTC KMT2A PRKDC CABIN1 DDX24 DYNC1H1 HSP90AA1	2.92e-05	1118	99	17	int:YWHAQ
Interaction	CTNNB1 interactions	ABCC1 SHROOM3 EZH2 BAP1 PTPN11 DST AASS RBMX KMT2A DLG4 PRKDC CTNNA2 IMMT TOP2A DYNC1H1 HSP90AA1	3.12e-05	1009	99	16	int:CTNNB1
Interaction	SUMO2 interactions	ABCF1 IARS1 RNF213 EZH2 NEDD4 NCAPG DST CLTC PRKDC TOP2A DYNC1H1 HSP90AA1	3.27e-05	591	99	12	int:SUMO2
Interaction	PPP1CA interactions	PFDN2 FRYL RYR2 BAP1 RBMX CD2BP2 CLTC DLG4 ADPRHL1 PRKDC TOP2A DYNC1H1 CNP	3.58e-05	696	99	13	int:PPP1CA
Interaction	ENO1 interactions	CLTCL1 EZH2 RYR3 BAP1 NEDD4 PTPN11 EIF2B2 DLG4 ASCC3 DDX24 IMMT DYNC1H1 HSP90AA1	3.85e-05	701	99	13	int:ENO1
Interaction	DYNLL1 interactions	RELCH CDR2 SHROOM3 MYO10 IARS1 EZH2 BAP1 NLN DLG4 MIGA1 DYNC1H1	4.14e-05	510	99	11	int:DYNLL1
Interaction	OGA interactions	RNF213 BAP1 PTPN11 RBMX DYNC1H1 HSP90AA1	4.21e-05	129	99	6	int:OGA
Interaction	NUDCD2 interactions	CPS1 EZH2 TTC6 RBMX NUP210 CLTC CSTF3 PRKDC DYNC1H1 HSP90AA1	4.49e-05	424	99	10	int:NUDCD2
Interaction	ATOH1 interactions	PSMC2 RNF213 RBMX PRKDC DYNC1H1	4.64e-05	80	99	5	int:ATOH1
Interaction	ATG16L1 interactions	SHROOM3 ACACB PSMC2 EXOC3 LCP1 DIS3 RYR2 TXNL4A RBMX NUP210 EIF2B2 CLTC CSTF3 ASCC3 IMMT TOP2A HSP90AA1	4.69e-05	1161	99	17	int:ATG16L1
Interaction	CRY2 interactions	IARS1 PSMC2 EZH2 PRKDC DYNC1H1 CNP HSP90AA1	4.85e-05	194	99	7	int:CRY2
Interaction	ACTG1 interactions	SHROOM3 MYO10 FPR1 LCP1 EZH2 DST RBMX CLTC PLD1 DNAH6 HSP90AA1	4.94e-05	520	99	11	int:ACTG1
Interaction	CAPZB interactions	IARS1 PSMC2 PFDN2 LCP1 EZH2 BAP1 NEDD4 FIG4 RBMX CLTC CABIN1 DDX24 IMMT TOP2A DYNC1H1 HSP90AA1	4.98e-05	1049	99	16	int:CAPZB
Interaction	GCN1 interactions	MYO10 FPR1 EZH2 BAP1 RBMX PRKDC CIAO2A TOP2A DYNC1H1	5.56e-05	349	99	9	int:GCN1
Interaction	ZNF598 interactions	IARS1 PSMC2 NCAPG NUP210 EIF2B2 CLTC PRKDC ASCC3 IMMT HSP90AA1	5.57e-05	435	99	10	int:ZNF598
Interaction	ERBB3 interactions	EYA4 PFDN2 SHC3 NEDD4 PTPN11 TXNL4A NUP210 TACC1 HSP90AA1	6.34e-05	355	99	9	int:ERBB3
Interaction	EIF2S1 interactions	CMTR1 EZH2 BAP1 EIF2B2 PRKDC DDX24 IMMT HSP90AA1	6.52e-05	276	99	8	int:EIF2S1
Interaction	MERTK interactions	RBM15 SHC3 PRKDC IMMT TOP2A HSP90AA1	6.66e-05	140	99	6	int:MERTK
Interaction	C9orf72 interactions	RBM15 DDX12P IARS1 PSMC2 BTAF1 DIS3 AASS RBMX CD2BP2 NUP210 EIF2B2 CLTC PRKDC ASCC3 IMMT DYNC1H1 CNP HSP90AA1	6.80e-05	1319	99	18	int:C9orf72
Interaction	MAP1B interactions	CMTR1 IARS1 PFDN2 CPS1 EZH2 BAP1 PRKDC IMMT DYNC1H1 CNP HSP90AA1	6.81e-05	539	99	11	int:MAP1B
Interaction	VDAC1 interactions	ABCC1 SLC25A20 IARS1 EZH2 BAP1 NEDD4 RBMXL2 CLTC DDX24 IMMT TOP2A	7.16e-05	542	99	11	int:VDAC1
Interaction	CDC5L interactions	SHROOM3 CMTR1 PSMC2 BTAF1 BAP1 DST GLE1 RBMX CD2BP2 CSTF3 PRKDC TOP2A DYNC1H1 HSP90AA1	7.32e-05	855	99	14	int:CDC5L
Interaction	GPR17 interactions	GJC1 EXOC3 RNF213 BTAF1 NCAPG EIF2B2 MIGA1 PRKDC	7.77e-05	283	99	8	int:GPR17
Interaction	RPS6KA5 interactions	EZH2 KMT2A PRKDC CIAO2A DYNC1H1 HSP90AA1	7.78e-05	144	99	6	int:RPS6KA5
Interaction	RET interactions	RBP3 LCP1 SHC3 NEDD4 PTPN11 TXNL4A TACC1 HSP90AA1	7.96e-05	284	99	8	int:RET
Interaction	ASXL1 interactions	PSMC2 EZH2 BAP1 RBMX CLTC PRKDC CNP HSP90AA1	8.36e-05	286	99	8	int:ASXL1
Interaction	FPR1 interactions	FPR1 EXOC3 RNF213 BTAF1 PRKDC PCCA	8.72e-05	147	99	6	int:FPR1
Interaction	AURKB interactions	CLTCL1 PSMC2 RNF213 CPS1 RBMX CLTC TACC1 PRKDC DDX24 TOP2A DYNC1H1 CNP HSP90AA1	8.88e-05	761	99	13	int:AURKB
Interaction	METTL14 interactions	ABCF1 CLTCL1 PSMC2 CPS1 RYR3 PTPN11 RBMX NUP210 PRKDC TOP2A HSP90AA1	9.27e-05	558	99	11	int:METTL14
Interaction	FABP5 interactions	EZH2 CCDC51 BAP1 NEDD4 CABIN1 DDX24	9.40e-05	149	99	6	int:FABP5
Interaction	HUWE1 interactions	ACACB IARS1 PSMC2 EZH2 DIS3 PPP4R3A BAP1 NCAPG CLTC DLG4 PRKDC PCCA DYNC1H1 CNP HSP90AA1 RAD23A	9.69e-05	1110	99	16	int:HUWE1
Interaction	KDR interactions	RBM15 PTPN11 PRKDC TOP2A CNP HSP90AA1	9.75e-05	150	99	6	int:KDR
Interaction	AHSA1 interactions	CLTCL1 IARS1 BAP1 RBMX CSTF3 PRKDC TOP2A HSP90AA1	1.01e-04	294	99	8	int:AHSA1
Interaction	PPP1CB interactions	RNF213 EZH2 RYR2 BAP1 DST RBMX CD2BP2 DLG4 DDX24 DYNC1H1	1.04e-04	469	99	10	int:PPP1CB
Interaction	FRK interactions	NUP210 IMMT DYNC1H1 HSP90AA1	1.06e-04	50	99	4	int:FRK
Interaction	NUCKS1 interactions	EZH2 PPP4R3A BAP1 RBMX KMT2A PRKDC TOP2A	1.07e-04	220	99	7	int:NUCKS1
Interaction	YWHAG interactions	CDR2 RBM15 SHROOM3 PFDN2 FRYL EZH2 BAP1 NEDD4 DST AASS CLTC IQSEC1 KMT2A DLG4 PRKDC DYNC1H1 HSP90AA1	1.14e-04	1248	99	17	int:YWHAG
Interaction	MEX3A interactions	MYO10 IARS1 DST CLTC TACC1 PRKDC TOP2A DYNC1H1 HSP90AA1	1.15e-04	384	99	9	int:MEX3A
Interaction	CDC73 interactions	CLTCL1 PSMC2 PTPN11 CLTC CSTF3 KMT2A PRKDC TOP2A HSP90AA1	1.20e-04	386	99	9	int:CDC73
Interaction	ATP1A1 interactions	CLTCL1 PSMC2 RNF213 CPS1 EZH2 BAP1 CLTC DLG4 PRKDC DYNC1H1 HSP90AA1	1.21e-04	575	99	11	int:ATP1A1
Interaction	PINK1 interactions	RBM15 SHROOM3 IARS1 DIS3 DST RBMX NUP210 CLTC PRKDC IMMT DYNC1H1 HSP90AA1	1.23e-04	679	99	12	int:PINK1
Interaction	TSR2 interactions	NEDD4 PTRHD1 DDX24 DYNC1H1	1.24e-04	52	99	4	int:TSR2
Interaction	OBSL1 interactions	RBM15 SHROOM3 ABCF1 EZH2 PPP4R3A DST RBMX CD2BP2 NUP210 CLTC PRKDC IMMT TOP2A DYNC1H1	1.29e-04	902	99	14	int:OBSL1
Interaction	PDGFRB interactions	NEDD4 PTPN11 DST NUP210 CLTC PRKDC HSP90AA1	1.33e-04	228	99	7	int:PDGFRB
Interaction	PSMC5 interactions	ABCC1 ABCF1 PSMC2 EZH2 BAP1 NCAPG KMT2A TOP2A DYNC1H1 RAD23A	1.34e-04	484	99	10	int:PSMC5
Interaction	KCTD13 interactions	ABCF1 IARS1 RBP3 ANKS1B PFDN2 TENM4 DST RBMX CLTC IQSEC1 KMT2A DLG4 CTNNA2 DNAH6 IMMT DYNC1H1 CNP HSP90AA1	1.37e-04	1394	99	18	int:KCTD13
Interaction	DCPS interactions	EZH2 GLE1 RBMX NUP210 CSTF3 PRKDC ASCC3 TOP2A DYNC1H1	1.40e-04	394	99	9	int:DCPS
Interaction	LGALS9 interactions	ABCC1 IARS1 PTPN11 NCAPG CLTC ASCC3 PCCA IMMT TOP2A DYNC1H1 HSP90AA1	1.47e-04	588	99	11	int:LGALS9
Interaction	DLST interactions	EZH2 NLN RBMXL2 CLTC PRKDC FASTKD3 DDX24 IMMT TOP2A DYNC1H1	1.48e-04	490	99	10	int:DLST
Interaction	ERBB2 interactions	IARS1 ANKS1B SHC3 PTPN11 DST CLTC DLG4 TACC1 PRKDC CNP HSP90AA1	1.49e-04	589	99	11	int:ERBB2
Interaction	CDK1 interactions	MYO10 EZH2 PPP4R3A BAP1 NCAPG RBMXL2 NUP210 ASCC3 CIAO2A TOP2A HSP90AA1	1.51e-04	590	99	11	int:CDK1
Interaction	S100A6 interactions	CDR2 EZH2 GLE1 CD2BP2 PTRHD1 KDM1B TOP2A	1.52e-04	233	99	7	int:S100A6
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR2 RYR3	3.35e-05	3	61	2	287
GeneFamily	EYA transcriptional coactivator and phosphatases	EYA4 EYA2	6.69e-05	4	61	2	1044
GeneFamily	EF-hand domain containing	VSNL1 LCP1 RYR2 RYR3 EFHC2 DST	9.40e-05	219	61	6	863
Coexpression	GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN	CMTR1 IARS1 EZH2 EFHC2 HARS2 RBMX TOP2A	3.38e-06	165	100	7	M6685
Coexpression	DODD_NASOPHARYNGEAL_CARCINOMA_UP	RBM15 IARS1 RNF213 PFDN2 EZH2 NEDD4 NLN KANSL2 NCAPG TXNL4A RBMX CSTF3 PRKDC ASCC3 CIAO2A FASTKD3 IMMT TOP2A	5.66e-06	1407	100	18	M14427
Coexpression	GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_UP	ABCF1 PSMC2 PFDN2 EZH2 GLE1 NUP210 DDX24	1.19e-05	200	100	7	M9493
Coexpression	GSE360_L_DONOVANI_VS_T_GONDII_DC_UP	VSNL1 EYA2 DIS3 BAP1 NEDD4 FIG4 CTNNA2	1.19e-05	200	100	7	M5195
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	PFDN2 FRYL DIS3 PPP4R3A NEDD4 PTPN11 CD2BP2 CLTC CIAO2A RAD23A	1.21e-05	467	100	10	M1347
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	PFDN2 FRYL DIS3 PPP4R3A NEDD4 PTPN11 CD2BP2 CLTC CIAO2A RAD23A	1.65e-05	484	100	10	MM999
Coexpression	CUI_TCF21_TARGETS_2_DN	SHROOM3 MYO10 FRYL BTAF1 ASB15 TENM2 CREBZF DST RDH16 IQSEC1 TACC1 PLD1 HSP90AA1	2.22e-05	854	100	13	M1533
Coexpression	CUI_TCF21_TARGETS_2_DN	SHROOM3 MYO10 FRYL BTAF1 ASB15 TENM2 CREBZF DST RDH16 IQSEC1 TACC1 PLD1 HSP90AA1	3.32e-05	888	100	13	MM1018
Coexpression	PUJANA_CHEK2_PCC_NETWORK	IARS1 PSMC2 EZH2 TXNL4A TBC1D31 RBMX NUP210 C1D PRKDC IMMT TOP2A HSP90AA1	3.34e-05	761	100	12	M11961
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	RBM15 CLTCL1 RNF213 LCP1 PTPN11 CLTC KMT2A HSP90AA1	3.40e-05	323	100	8	M9150
Coexpression	GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN	EXOC3 PTPN11 FIG4 CLTC IMMT TOP2A	4.15e-05	165	100	6	M8121
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN	IARS1 NEDD4 NCAPG FIG4 PCCA TOP2A	1.14e-04	198	100	6	M8274
Coexpression	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP	CPS1 CCDC51 NEDD4 NUP210 CNP RAD23A	1.14e-04	198	100	6	M4982
Coexpression	GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN	EYA2 AXDND1 TBC1D31 GLE1 TXNL4B MIGA1	1.17e-04	199	100	6	M4670
Coexpression	GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP	ABCF1 BAP1 HARS2 TENM4 CD2BP2 EIF2B2	1.17e-04	199	100	6	M9019
Coexpression	GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN	BTAF1 KANSL2 GLE1 ASCC3 PCCA HSP90AA1	1.20e-04	200	100	6	M5081
Coexpression	GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP	SHROOM3 EYA2 RYR3 EFHC2 AASS CTNNA2	1.20e-04	200	100	6	M7777
Coexpression	GSE14026_TH1_VS_TH17_UP	VSNL1 MYO10 FPR1 LCP1 PPP4R3A RBMXL2	1.20e-04	200	100	6	M3356
Coexpression	GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN	IARS1 CCDC51 NEDD4 NCAPG CLTC TOP2A	1.20e-04	200	100	6	M5303
Coexpression	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	ABCC1 MYO10 BTAF1 CREBZF BAP1 PTPN11 KANSL2 FASTKD3	1.72e-04	408	100	8	M11891
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 CPS1 RYR2 RYR3 RDH16 AASS CTNNA2	8.19e-08	160	101	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 CPS1 RYR2 RYR3 RDH16 AASS CTNNA2	8.19e-08	160	101	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	SHROOM3 CNNM2 FAT3 ANKS1B RYR2 RYR3 SLC35F4	2.46e-07	188	101	7	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 FRYL DST CLTC KMT2A ASCC3 DYNC1H1	3.14e-07	195	101	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EYA4 VSNL1 ANKS1B EYA2 TENM2 TTC6 TENM4	3.37e-07	197	101	7	1e915957ea6a4550ecb9d6ee4b232aa5800faf20
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	RNF213 LCP1 KMT2A TACC1 DDX24 DYNC1H1 HSP90AA1	3.73e-07	200	101	7	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RBM15 CPS1 GSTA1 NCAPG FASTKD3 TOP2A	1.97e-06	163	101	6	2d6fd2562d78be9f83fa35d811eb7e27eb8cc5d1
ToppCell	Basal_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	CNNM2 GPR143 RYR2 GSTA1 RDH16 ADPRHL1	2.04e-06	164	101	6	b15a26130a1ea1b370b6e3be21f02a0d6aaf6b3c
ToppCell	droplet-Limb_Muscle-nan-3m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACACB CERT1 TXNL4B NUP210 PRKDC TOP2A	2.19e-06	166	101	6	35db3022c33d6f8bb6587d9eec89a7cccb70271a
ToppCell	3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP2C19 ACACB CPS1 TENM2 GSTA1 NEDD4	2.34e-06	168	101	6	4e2e4c88ada772e9ba6e72c9ae3a05c063e93318
ToppCell	3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP2C19 ACACB CPS1 TENM2 GSTA1 NEDD4	2.34e-06	168	101	6	ee4dab089adef2f47a9d39d91934523331a8b81c
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VSNL1 FAT3 ANKS1B GPR143 RYR2 TENM4	3.84e-06	183	101	6	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	EYA4 ACACB TENM2 RYR2 DST ADPRHL1	3.96e-06	184	101	6	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	COVID-19-kidney-T-cells-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ABCC1 LCP1 EZH2 NCAPG NUP210 HSP90AA1	4.48e-06	188	101	6	15484c05cb496cd98ed3f79a6134c5cec8f09a4d
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	SHROOM3 CNNM2 FAT3 ANKS1B RYR3 SLC35F4	4.62e-06	189	101	6	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	FRYL CLTC MIGA1 PRKDC KDM1B DYNC1H1	5.21e-06	193	101	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO10 FAT3 TENM2 RYR2 DST AASS	5.21e-06	193	101	6	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO10 FAT3 TENM2 RYR2 DST AASS	5.21e-06	193	101	6	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYO10 FAT3 ANKS1B TENM2 DST PCCA	5.36e-06	194	101	6	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO10 FAT3 TENM2 RYR2 TENM4 DST	5.36e-06	194	101	6	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MYO10 FAT3 ANKS1B TENM2 DST PCCA	5.52e-06	195	101	6	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRYL DST CLTC KMT2A ASCC3 DYNC1H1	5.52e-06	195	101	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	VSNL1 ANKS1B TENM2 RYR2 TENM4 DDX24	6.03e-06	198	101	6	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYO10 PSMC2 RYR3 AASS PRKDC CTNNA2	6.21e-06	199	101	6	a900ef002e1ae583b70be0253d8c44dae6754916
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EYA4 VSNL1 GPR143 EYA2 TENM4 PLD1	6.21e-06	199	101	6	f5c3561744e2a0e7716657cb521acb1d8f054b41
ToppCell	Macroglial-Astrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SHROOM3 ACACB EYA2 TENM2 RYR3 CTNNA2	6.39e-06	200	101	6	941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCell	Macroglial-Astrocytes-SLC14A1---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SHROOM3 ACACB EYA2 TENM2 RYR3 CTNNA2	6.39e-06	200	101	6	d6fcbf4f4bc1b89a9929d7b114c6b907b6979900
ToppCell	Macroglial-Astrocytes-SLC14A1----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SHROOM3 ACACB EYA2 TENM2 RYR3 CTNNA2	6.39e-06	200	101	6	f861509b54185d89931db64da1b9d81986cc7938
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF213 FRYL BTAF1 KMT2A DDX24 DYNC1H1	6.39e-06	200	101	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Macroglial-Astrocytes-SLC14A1\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SHROOM3 ACACB EYA2 TENM2 RYR3 CTNNA2	6.39e-06	200	101	6	16f468217427921fa18c6d078ffa990eb019b257
ToppCell	Macroglial-Astrocytes-GFAP---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CFAP47 SHROOM3 FAT3 TENM2 RYR3 CTNNA2	6.39e-06	200	101	6	88d66550781a3c9102ff7455f5cff6fb072943cd
ToppCell	Macroglial-Astrocytes-GFAP-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CFAP47 SHROOM3 FAT3 TENM2 RYR3 CTNNA2	6.39e-06	200	101	6	d6a059b0ef763c281c60b1ac76da6079ea822f80
ToppCell	Macroglial-Astrocytes-GFAP--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CFAP47 SHROOM3 FAT3 TENM2 RYR3 CTNNA2	6.39e-06	200	101	6	16269fa4adb28fc6ed032bbdba8781237dd0d249
ToppCell	Macroglial-Astrocytes-GFAP----L1-2\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CFAP47 SHROOM3 FAT3 TENM2 RYR3 CTNNA2	6.39e-06	200	101	6	c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f
ToppCell	Macroglial-Astrocytes-SLC14A1--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SHROOM3 ACACB EYA2 TENM2 RYR3 CTNNA2	6.39e-06	200	101	6	0442894c39eec69850c090957a5dc7bcecd21e04
ToppCell	Macroglial-Astrocytes-GFAP\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CFAP47 SHROOM3 FAT3 TENM2 RYR3 CTNNA2	6.39e-06	200	101	6	79634b1086934412ae92f259ab43554ce545008f
ToppCell	Macroglial-Astrocytes-SLC14A1-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SHROOM3 ACACB EYA2 TENM2 RYR3 CTNNA2	6.39e-06	200	101	6	01819446deeab9054f5cfe889d53bb49d137dbc0
ToppCell	LPS-antiTNF-Unknown-Endothelial-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GJC1 RYR2 RYR3 NCAPG TOP2A	1.27e-05	132	101	5	02491930097b75aaeedab9e8200711b0dc610944
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RNF213 BTAF1 CREBZF GSTA1 DYNC1H1	2.14e-05	147	101	5	94998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCell	Basal_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	VSNL1 EYA2 TENM2 TTC6 GSTA1	2.51e-05	152	101	5	72499e4d2b374ef5f1621c89d94727ecf4bd4d5d
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	FAT3 TENM2 TTC6 RYR2 CTNNA2	3.12e-05	159	101	5	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	Ciliated_cells-B-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	EYA4 RYR3 EFHC2 DNAH6 C22orf15	3.62e-05	164	101	5	0e9961acbb1d6c0089e6805ba6756736fa4d8bed
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 RYR2 RYR3 DNAH6 HSP90AA1	4.17e-05	169	101	5	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FPR1 LCP1 EZH2 NCAPG TOP2A	4.54e-05	172	101	5	ef33b5e0515c6d29fb6d9a673011c1b68ef264f3
ToppCell	droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_NK\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EZH2 HARS2 NCAPG FASTKD3 TOP2A	4.66e-05	173	101	5	31784679190fbd95fc23d7c66008eb21b8c7cc5d
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNNM2 VSNL1 MYO10 GJC1 RYR2	5.34e-05	178	101	5	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ABCC1 MYO10 RYR2 TACC1 CTNNA2	5.48e-05	179	101	5	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EYA4 MYO10 FAT3 TENM2 RYR2	5.78e-05	181	101	5	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHROOM3 VSNL1 GJC1 ASB15 TENM4	5.93e-05	182	101	5	9edaccf1154cec92ca9a28e9b1f9075cfd422bfd
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHROOM3 VSNL1 GJC1 ASB15 TENM4	5.93e-05	182	101	5	aba4c06d5d7618ac21b2695bca8e7a1346a91090
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 CPS1 RYR2 RYR3 TENM4	6.25e-05	184	101	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3\|TCGA-Lung / Sample_Type by Project: Shred V9	ABCC1 VSNL1 TENM2 TENM4 PLD1	6.25e-05	184	101	5	ea4ccebe2d54279fcc517e4f0bfa652b91a808bb
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EYA4 TENM2 RYR3 SLC35F4 PLD1	6.25e-05	184	101	5	658f2e522055e88c92bc482a845c40f8f5f1a8e3
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 CPS1 RYR2 RYR3 TENM4	6.25e-05	184	101	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 CPS1 RYR2 RYR3 TENM4	6.25e-05	184	101	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EYA4 ASB15 TENM2 RYR2 ADPRHL1	6.25e-05	184	101	5	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	PBMC-Mild-cDC_9\|Mild / Compartment, Disease Groups and Clusters	RNF213 LCP1 NCAPG TOP2A HSP90AA1	6.25e-05	184	101	5	2e0c9a2c40c892a2d435eafb31f1f838de9baf15
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	EYA4 TENM2 RYR2 RYR3 TENM4	6.41e-05	185	101	5	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	FAT3 TENM2 RYR2 TENM4 DST	6.74e-05	187	101	5	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CNNM2 MYO10 GJC1 RYR2 TACC1	6.74e-05	187	101	5	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RELCH CMTR1 RYR2 GLE1 KMT2A	6.91e-05	188	101	5	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RELCH CMTR1 RYR2 GLE1 KMT2A	6.91e-05	188	101	5	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RELCH CMTR1 RYR2 GLE1 KMT2A	6.91e-05	188	101	5	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EZH2 NCAPG NUP210 TOP2A HSP90AA1	6.91e-05	188	101	5	567b08514d9d84cbb40f9b7a679eec304f023428
ToppCell	droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FPR1 LCP1 DST CLTC IQSEC1	7.09e-05	189	101	5	b2542b6fcf7bc10d29158d42b03182a939ff135a
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	VSNL1 MYO10 GJC1 RYR2 TACC1	7.09e-05	189	101	5	d7ed96add29f219183c802895fbff519b627f635
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	ACACB ASB15 TENM2 RYR2 ADPRHL1	7.27e-05	190	101	5	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	pdx-Tumor_cells-T8\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	SLC25A20 VSNL1 CPS1 GSTA1 DST	7.27e-05	190	101	5	b05db0de9b6ae01dd30074453f7de44f7397631e
ToppCell	droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FPR1 LCP1 DST CLTC IQSEC1	7.27e-05	190	101	5	da58227565ad6a690828dd8554dd3670222f8582
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	MYO10 FAT3 GSTA1 DST TACC1	7.27e-05	190	101	5	71e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	ACACB TENM2 RYR2 DST ADPRHL1	7.27e-05	190	101	5	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	ACACB TENM2 RYR2 DST ADPRHL1	7.45e-05	191	101	5	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LCP1 EZH2 NCAPG NUP210 TOP2A	7.45e-05	191	101	5	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	EYA4 ACACB FAT3 ANKS1B TACC1	7.64e-05	192	101	5	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	EYA4 ACACB TENM2 RYR2 ADPRHL1	7.64e-05	192	101	5	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EYA4 VSNL1 FAT3 ANKS1B TENM4	7.64e-05	192	101	5	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VSNL1 EZH2 NCAPG TENM4 TOP2A	7.82e-05	193	101	5	a332dfdcc48c405020014e644aa4d14fda98cc86
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RELCH RNF213 FRYL BTAF1 DDX24	7.82e-05	193	101	5	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	MYO10 FAT3 TENM2 RYR2 DST	7.82e-05	193	101	5	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO10 FAT3 RYR2 DST AASS	8.02e-05	194	101	5	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO10 FAT3 TENM2 RYR2 DST	8.02e-05	194	101	5	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	wk_15-18-Hematologic_Lymphocytic-NK-Cycling_NK\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	LCP1 EZH2 NCAPG NUP210 TOP2A	8.02e-05	194	101	5	af08047e5728ee8198d2686af6a774f2acfa58ba
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	EYA4 ACACB TENM2 RYR2 ADPRHL1	8.02e-05	194	101	5	c3535f7cc0076653c72db582047cff053c322397
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SHROOM3 FAT3 FPR1 CPS1 RYR3	8.21e-05	195	101	5	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SHROOM3 FAT3 FPR1 CPS1 RYR3	8.21e-05	195	101	5	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	EYA4 TENM2 RYR2 DST ADPRHL1	8.21e-05	195	101	5	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNNM2 VSNL1 GJC1 RYR2 TACC1	8.41e-05	196	101	5	754a3613340932563cd8424d775e18b93c3a1aaa
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	CFAP47 SHROOM3 EYA2 TTC6 DNAH6	8.41e-05	196	101	5	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF213 FRYL BTAF1 KMT2A DDX24	8.62e-05	197	101	5	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFAP47 EFHC2 AXDND1 DNAH6 TOP2A	8.62e-05	197	101	5	6e4a411ef823ce9e16f420e185e21fa19d13af34
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VSNL1 TENM2 RYR2 TENM4 DST	8.62e-05	197	101	5	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CFAP47 EFHC2 DNAH6 C22orf15 TOP2A	8.83e-05	198	101	5	f31790442ef142f1c0c49bf3daf2d0efb193d2c9
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FAT3 EZH2 NCAPG PRKDC TOP2A	8.83e-05	198	101	5	7225a6194c52b01c581e58d3cda107c4af96dc4f
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EYA4 VSNL1 EYA2 TENM4 TOP2A	8.83e-05	198	101	5	19d8ff3a4f911b13ecc34844202925475ad4d2ab
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RELCH RNF213 FRYL BTAF1 DDX24	9.04e-05	199	101	5	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Severe\|World / Disease group and Cell class	EZH2 NCAPG TXNL4A TOP2A HSP90AA1	9.04e-05	199	101	5	b73ae402b258fcc17e6cd6d6045244eccfe38ef8
ToppCell	3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SI CPS1 GSTA1 TOP2A HSP90AA1	9.04e-05	199	101	5	06cf08b4a60670f583895a79488524b7b386b2f0
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EZH2 NCAPG DST TOP2A CNP	9.04e-05	199	101	5	9940f347973bf976ee23fb4b1cf1f349d96c21df
ToppCell	5'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO10 SI CPS1 GSTA1 PTRHD1	9.25e-05	200	101	5	fc77a0c53201c60933d188ea8d4d86bac6325422
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CFAP47 GSTA1 EFHC2 DNAH6 C22orf15	9.25e-05	200	101	5	ddd39b754bfaa98249d497dfb7e97ec58617a11a
Computational	Neighborhood of DEAF1	IARS1 TXNL4A PRKDC IMMT RAD23A	5.18e-05	57	77	5	MORF_DEAF1
Computational	Neighborhood of BUB1B	ABCF1 IARS1 PRKDC IMMT TOP2A	1.05e-04	66	77	5	MORF_BUB1B
Drug	4-hydroxycyclophosphamide	ABCC1 CYP2C19 GSTA1 CLTC PRKDC	6.61e-07	38	100	5	CID000099735
Drug	Isoflupredone acetate [338-98-7]; Up 200; 9.6uM; PC3; HT_HG-U133A	EYA4 CLTCL1 ACACB CPS1 CREBZF PTPN11 GLE1 CSTF3	1.81e-06	188	100	8	1832_UP
Drug	GSK-3beta Inhibitor VIII; Down 200; 10uM; PC3; HT_HG-U133A	ACACB CREBZF PTPN11 TXNL4A TENM4 GLE1 CD2BP2 CSTF3	2.04e-06	191	100	8	7070_DN
Drug	hypericin	ABCC1 GSTA1 TOP2A	4.53e-06	8	100	3	ctd:C004965
Drug	PtdIns(4)P	VSNL1 CLTCL1 CERT1 FIG4 CLTC PLD1	6.61e-06	104	100	6	CID000643965
Drug	LOPAC	CDR2 RYR2 RYR3 IMMT	8.79e-06	30	100	4	CID000062696
Drug	lexitropsin	TXNL4A DST TXNL4B	1.32e-05	11	100	3	CID000119575
Drug	AC1L1D8L	FPR1 RYR2 RYR3 CABIN1 HSP90AA1	1.53e-05	71	100	5	CID000002241
Drug	Badg	CLTCL1 CLTC	1.91e-05	2	100	2	CID000125951
Drug	Indoles	CYP2C19 LCP1 NEDD4 HSP90AA1	2.56e-05	39	100	4	ctd:D007211
Drug	indium phosphide	CLTCL1 FIG4 CLTC PLD1	2.84e-05	40	100	4	CID000031170
Drug	thiocarbohydrazide	CLTCL1 LCP1 CLTC	2.89e-05	14	100	3	CID002724189
Drug	Fm 4-64	CLTCL1 TXNL4A TXNL4B CLTC DYNC1H1	4.83e-05	90	100	5	CID002733635
Drug	cis-diammineplatinum(II	RYR2 RYR3	5.71e-05	3	100	2	CID000159790
Drug	2-hydroxyheptanoic acid	RYR2 RYR3	5.71e-05	3	100	2	CID002750949
Drug	8N3-cADPR	RYR2 RYR3	5.71e-05	3	100	2	CID000127713
Drug	aminodantrolene	RYR2 RYR3	5.71e-05	3	100	2	CID009570289
Drug	2-hydroxycarbazole	RYR2 RYR3	5.71e-05	3	100	2	CID000093551
Drug	Lr16	CDR2 RBP3	5.71e-05	3	100	2	CID003082814
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR2 RYR3	5.71e-05	3	100	2	CID005748312
Drug	AC1L1GXW	CLTCL1 CLTC DLG4 PLD1 HSP90AA1	5.95e-05	94	100	5	CID000003891
Drug	Adenosine Diphosphate	ABCC1 CYP2C19 CPS1 HSP90AA1	7.47e-05	51	100	4	ctd:D000244
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR2 RYR3	3.40e-05	3	100	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR2 RYR3	3.40e-05	3	100	2	DOID:8545 (implicated_via_orthology)
Disease	leukemia	BAP1 PTPN11 KMT2A TOP2A	3.71e-05	55	100	4	C0023418
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	SHROOM3 CPS1 LCP1 CERT1 DLG4	5.89e-05	121	100	5	EFO_0008595, EFO_0020943
Disease	gamma-glutamylcitrulline measurement	ABCC1 CPS1	6.79e-05	4	100	2	EFO_0800690
Disease	alcohol dependence, heroin dependence, methamphetamine dependence	ANKS1B CTNNA2	6.79e-05	4	100	2	EFO_0004240, EFO_0004701, MONDO_0007079
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	CPS1 LCP1 TXNL4B DLG4	8.08e-05	67	100	4	EFO_0008595, EFO_0020946
Disease	Weaver syndrome	EZH2 KMT2A	1.13e-04	5	100	2	C0265210
Disease	Intellectual Disability	CERT1 AASS PTRHD1 IQSEC1 DLG4 CTNNA2 ASCC3 DYNC1H1	1.44e-04	447	100	8	C3714756
Disease	eye disease (implicated_via_orthology)	EYA4 EYA2	1.69e-04	6	100	2	DOID:5614 (implicated_via_orthology)
Disease	acute lymphoblastic leukemia (implicated_via_orthology)	EZH2 KMT2A	1.69e-04	6	100	2	DOID:9952 (implicated_via_orthology)
Disease	coronary artery disease	SHROOM3 CNNM2 CLTCL1 RNF213 LCP1 CERT1 NEDD4 TXNL4B RBMX NUP210 EIF2B2 C1D CABIN1	1.98e-04	1194	100	13	EFO_0001645
Disease	Solid Neoplasm	EZH2 PTPN11	2.36e-04	7	100	2	C0280100
Disease	branchiootorenal syndrome (implicated_via_orthology)	EYA4 EYA2	2.36e-04	7	100	2	DOID:14702 (implicated_via_orthology)
Disease	Neurodevelopmental Disorders	CERT1 PTPN11 KMT2A DLG4	2.88e-04	93	100	4	C1535926
Disease	cancer (implicated_via_orthology)	PSMC2 TXNL4A DST DLG4 TOP2A HSP90AA1	3.10e-04	268	100	6	DOID:162 (implicated_via_orthology)
Disease	myelofibrosis (is_implicated_in)	EZH2 KMT2A	3.14e-04	8	100	2	DOID:4971 (is_implicated_in)
Disease	Moyamoya disease	RNF213 NLN C1D	3.41e-04	40	100	3	MONDO_0016820
Disease	attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia	CNNM2 ANKS1B TENM4 KMT2A	3.94e-04	101	100	4	EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	CPS1 LCP1 CERT1 DLG4	4.25e-04	103	100	4	EFO_0008595, EFO_0020944
Disease	brain connectivity measurement	CNNM2 FAT3 PPP4R3A NEDD4 TENM4 EIF2B2 PCCA	4.33e-04	400	100	7	EFO_0005210
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	ACACB CPS1 LCP1 CERT1 TENM4 TXNL4B	4.79e-04	291	100	6	EFO_0008317, EFO_0020946
Disease	free cholesterol in small VLDL measurement	LCP1 CERT1 TXNL4B	5.50e-04	47	100	3	EFO_0022272
Disease	free cholesterol in medium VLDL measurement	LCP1 CERT1 TXNL4B	5.50e-04	47	100	3	EFO_0022269
Disease	apolipoprotein B to apolipoprotein A1 ratio	LCP1 CERT1 TXNL4B	6.21e-04	49	100	3	EFO_0021897
Disease	low density lipoprotein cholesterol measurement, lipid measurement	LCP1 CERT1 PTPN11 TXNL4B	6.23e-04	114	100	4	EFO_0004529, EFO_0004611
Disease	fatty acid measurement	ACACB MYO10 LCP1 CERT1 TXNL4B KMT2A CTNNA2	7.21e-04	436	100	7	EFO_0005110
Disease	acute myeloid leukemia (implicated_via_orthology)	KMT2A TOP2A	7.34e-04	12	100	2	DOID:9119 (implicated_via_orthology)
Disease	phospholipids in medium VLDL measurement	LCP1 CERT1 TXNL4B	7.40e-04	52	100	3	EFO_0022154
Disease	cholesterol in small VLDL measurement	LCP1 CERT1 TXNL4B	7.82e-04	53	100	3	EFO_0022228
Disease	free cholesterol in small LDL measurement	LCP1 CERT1 TXNL4B	7.82e-04	53	100	3	EFO_0022271
Disease	total lipids in medium VLDL	LCP1 CERT1 TXNL4B	8.26e-04	54	100	3	EFO_0022153
Disease	glutaroyl carnitine measurement	ABCC1 CPS1	8.66e-04	13	100	2	EFO_0021005
Disease	cholesteryl ester measurement, low density lipoprotein cholesterol measurement	LCP1 CERT1 PTPN11 TXNL4B	9.06e-04	126	100	4	EFO_0004611, EFO_0010351
Disease	malignant pleural mesothelioma (is_marker_for)	EZH2 BAP1	1.01e-03	14	100	2	DOID:7474 (is_marker_for)
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	SHROOM3 ACACB LCP1 CERT1 TXNL4B	1.01e-03	224	100	5	EFO_0004530, EFO_0008317
Disease	phospholipids in VLDL measurement	LCP1 CERT1 TXNL4B	1.07e-03	59	100	3	EFO_0022301
Disease	phospholipids in small VLDL measurement	LCP1 CERT1 TXNL4B	1.12e-03	60	100	3	EFO_0022146
Disease	total lipids in VLDL measurement	LCP1 CERT1 TXNL4B	1.12e-03	60	100	3	EFO_0022314
Disease	free cholesterol in VLDL measurement	LCP1 CERT1 TXNL4B	1.18e-03	61	100	3	EFO_0022276
Disease	urate measurement, bone density	CDR2 DDX12P LCP1 TENM2 SHC3 PRKDC CTNNA2 CABIN1	1.23e-03	619	100	8	EFO_0003923, EFO_0004531
Disease	free cholesterol measurement, low density lipoprotein cholesterol measurement	LCP1 PTPN11 TXNL4B DLG4	1.24e-03	137	100	4	EFO_0004611, EFO_0008591
Disease	cholesterol in large VLDL measurement	LCP1 CERT1 TXNL4B	1.42e-03	65	100	3	EFO_0021902
Disease	cholesterol in very large VLDL measurement	LCP1 CERT1 TXNL4B	1.42e-03	65	100	3	EFO_0022230
Disease	glutarylcarnitine (C5-DC) measurement	ABCC1 CPS1	1.50e-03	17	100	2	EFO_0800030
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	CNNM2 BTAF1 TENM2 SHC3 RYR2 TENM4 PRKDC CTNNA2 ASCC3	1.61e-03	801	100	9	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	Adrenocortical carcinoma	BAP1 TOP2A	1.68e-03	18	100	2	C0206686
Disease	Juvenile Myelomonocytic Leukemia	EZH2 PTPN11	1.87e-03	19	100	2	C0349639
Disease	intrahepatic cholangiocarcinoma (is_marker_for)	BAP1 HSP90AA1	1.87e-03	19	100	2	DOID:4928 (is_marker_for)
Disease	apolipoprotein B measurement	ACACB LCP1 CERT1 PTPN11 NCAPG FIG4 TXNL4B DLG4	1.89e-03	663	100	8	EFO_0004615
Disease	unipolar depression, bipolar disorder	CNNM2 TENM2 TENM4 ASCC3	1.99e-03	156	100	4	EFO_0003761, MONDO_0004985
Disease	HbA1c measurement	ABCC1 ACACB ASB15 SHC3 TTC6 PTPN11 FIG4 PLD1	2.12e-03	675	100	8	EFO_0004541
Disease	amino acid measurement	CLTCL1 ACACB CPS1 RYR2 RYR3 TENM4 RBMX PRKDC	2.17e-03	678	100	8	EFO_0005134
Disease	carnitine measurement	ABCC1 CPS1 PCCA	2.22e-03	76	100	3	EFO_0010469
Disease	cerebellar cortex volume measurement	CPS1 TTC6	2.29e-03	21	100	2	EFO_0010291
Disease	Disease Exacerbation	ABCC1 ABCF1 TOP2A RAD23A	2.44e-03	165	100	4	C0235874
Disease	citrate measurement	SHROOM3 CLTCL1 CPS1	2.48e-03	79	100	3	EFO_0010114
Disease	Drug-Induced Liver Disease	ABCC1 CYP2C19 CPS1 AASS PRKDC IMMT	2.57e-03	404	100	6	C0860207
Disease	Drug-Induced Acute Liver Injury	ABCC1 CYP2C19 CPS1 AASS PRKDC IMMT	2.57e-03	404	100	6	C3658290
Disease	Hepatitis, Toxic	ABCC1 CYP2C19 CPS1 AASS PRKDC IMMT	2.57e-03	404	100	6	C0019193
Disease	Chemically-Induced Liver Toxicity	ABCC1 CYP2C19 CPS1 AASS PRKDC IMMT	2.57e-03	404	100	6	C4279912
Disease	Chemical and Drug Induced Liver Injury	ABCC1 CYP2C19 CPS1 AASS PRKDC IMMT	2.57e-03	404	100	6	C4277682
Disease	Hepatitis, Drug-Induced	ABCC1 CYP2C19 CPS1 AASS PRKDC IMMT	2.57e-03	404	100	6	C1262760
Disease	empathy measurement	SHROOM3 CMTR1 AXDND1 TENM4	2.71e-03	170	100	4	EFO_0009183
Disease	susceptibility to childhood ear infection measurement	TENM2 NUP210 IQSEC1 CTNNA2	2.77e-03	171	100	4	EFO_0007904
Disease	migraine disorder, Headache	RNF213 RDH16 C1D	3.15e-03	86	100	3	HP_0002315, MONDO_0005277

Protein segments in the cluster

Peptide	Gene	Start	Entry
TRQEVLEMRKIVAEY	TACC1	631	O75410
DYKREVLEALGEVMV	ABCF1	826	Q8NE71
IRLIDYEKMVDHRGV	AASS	131	Q9UDR5
KHLVGRVTRVLIDYM	ASB15	491	Q8WXK1
MAVVPDRRIKYEARL	BAP1	231	Q92560
IKVEGCVRMYELVHR	GLE1	126	Q53GS7
RIMEEKALEVYDLIR	CIAO2A	31	Q9H5X1
IRDYRIDEKNFVVVM	RAD23A	61	P54725
AKSEEDYLVMIIVRG	RBM15	941	Q96T37
YGRIVEVLLMKDRET	RBMX	31	P38159
IKERALIDMYIEGIA	GSTA1	86	P08263
YVERLKGMSLLVRAE	PPP4R3A	31	Q6IN85
GIRGYMKTVVLDLLR	ACACB	1121	O00763
KVVCMASLEVYVRRG	ACACB	1286	O00763
EMKVYRREVEENGIV	CERT1	426	Q9Y5P4
DLAALYGRLRVVKMI	ANKS1B	166	Q7Z6G8
YKEVVVSVPQRIMAR	NUP210	1546	Q8TEM1
VREAVIKSLGIIMGY	RELCH	656	Q9P260
IYVLVRIIKGEDMAS	C22orf15	76	Q8WYQ4
EVMRALRRVLGKYIL	OR2AG2	296	A6NM03
VLEDSYRRIMGVKRA	NEDD4	971	P46934
LYETLKQRGEEMIAR	DST	6101	Q03001
VEMLERKYGGRLVTR	IQSEC1	121	Q6DN90
VEMGVKSNYEIRIRR	KIAA2026	561	Q5HYC2
ELERIRVYMNRVKEI	C1D	86	Q13901
YMKIRREVVEHVEPL	EFHC2	196	Q5JST6
ADALKYVGIEREMEI	EZH2	731	Q15910
ETRKCYRMVGGVLVE	PFDN2	66	Q9UHV9
YRMVGGVLVERTVKE	PFDN2	71	Q9UHV9
AISMARKIGARVYAL	LCP1	586	P13796
ARRVAKEYETVMKGL	CSTF3	216	Q12996
VIVYLGRDKTMQLLE	FRYL	1426	O94915
GMLETVRIRKAGYAV	MYO10	661	Q9HD67
RGIYKGTVLTLMRDV	SLC25A20	166	O43772
YAVQKLARRVAMIDE	IMMT	636	Q16891
ALKEYGVMRVRNVKE	PTPN11	376	Q06124
VRIAREIGYPVMIKA	PCCA	206	P05165
GVYQETRERLAMRLK	CD2BP2	216	O95400
IYGVDTRMLTKIIRD	CPS1	161	P31327
RAMDLYSRVVKVVEP	DNAH6	2886	Q9C0G6
ERIMQRFGRKVVYVV	EYA4	586	O95677
VQEVERILYFMTRKG	KDM1B	346	Q8NB78
VQRDRMIYDGVDRKI	BMP10	151	O95393
MIYDGVDRKITIFEV	BMP10	156	O95393
QKGVAYDLGRVERIM	CABIN1	1871	Q9Y6J0
LERMVVLHGYEVVKE	CYP2C19	71	P33261
VYDGVRDIRKAVLMI	CTNNA2	616	P26232
VYRLITRGTLEEKIM	BTAF1	1751	O14981
LERQKRVTMEEEYGL	CDR2	211	Q01850
YIVLITKRRKMADIG	FIG4	106	Q92562
RRIREDGLMKIYVLQ	GJC1	166	P36383
GELLSKVRERYVQML	AXDND1	281	Q5T1B0
YTENERRMGAVIKIR	GPR143	231	P51810
RYDLEILAVDRGMKL	FAT3	226	Q8TDW7
MAELYRVLEAGKIGI	DDX12P	46	Q92771
REMVRCYVEIVEKLP	ADPRHL1	81	Q8NDY3
LARVIVDKYRDGTKM	CNP	66	P09543
ALKEAGSIVRLYVMR	DLG4	136	P78352
YMDVVKERIRLARQI	DDX24	721	Q9GZR7
RQLTAYMKRVEDVLG	DYNC1H1	656	Q14204
VYTAEEVALIMREKL	KANSL2	186	Q9H9L4
IVIFAMRKIYRGEEL	KMT2A	3926	Q03164
NRIYRMIKLGLGIDE	HSP90AA1	686	P07900
MVRRVLKIIREEYGR	EIF2B2	81	P49770
RVVVEYLRAVMQKRI	EXOC3	601	O60645
IEIMGSAKRIERVYF	RYR2	4136	Q92736
EVKFLDTMAGRVYRL	CFAP47	46	Q6ZTR5
VYRLEEMEKIFVRLE	CMTR1	706	Q8N1G2
IMDYTRVIVLDKGEI	ABCC1	1491	P33527
RIMQRFGRKAVYVVI	EYA2	486	O00167
VEEGKIYSRVLRTEM	MIGA1	361	Q8NAN2
VQKYVGEGARMVREL	PSMC2	246	P35998
GVERIFYIVEQRMKT	HARS2	386	P49590
ELRRLDDEIGRKVYM	TBC1D31	791	Q96DN5
YLQELGRMRKVVLEA	PTRHD1	71	Q6GMV3
EKVFMVARGLVREAR	CCDC51	106	Q96ER9
QGVRIFIMLYKEVEL	PLD1	411	Q13393
RRELSYFGVKVAMIE	RDH16	191	O75452
YHEIGMLKSRRELVE	FASTKD3	631	Q14CZ7
VRIRELLQGMYKEIG	FPR1	266	P21462
VVKYLGCIEVLRSMR	SHC3	156	Q92529
LEGMRQADIRYVKTV	SHROOM3	296	Q8TF72
TVQYDSMGRVIKREL	TENM2	2176	Q9NT68
EMQYVKIKDVARGRL	IARS1	241	P41252
FVDKIRGEGMRYIII	SI	1281	P14410
VLKDRFMGVRIVAAI	SLC35F4	296	A4IF30
YGRIVEVLLMKDRET	RBMXL2	31	O75526
VMKIVREHYLRDDIG	DIS3	16	Q9Y2L1
VYIAPLKALVRERMD	ASCC3	1376	Q8N3C0
RVVGAMQLYSVDRKV	CLTC	176	Q00610
RVVGAMQLYSVDRKV	CLTCL1	176	P53675
MVVYKREPAVERVIE	NCAPG	56	Q9BPX3
GTVYNREKLLEMLRV	CNNM2	406	Q9H8M5
ALADVEVKYIVERTM	NLN	91	Q9BYT8
IKRDVMTRDLYQGLL	RNF213	2341	Q63HN8
ITRVEMLEIIEAIYK	VSNL1	116	P62760
KIRELQMALTDYGIV	TTC6	151	Q86TZ1
YIMKRLGRALVIGEV	RBP3	1156	P10745
RIEIMGGAKKIERVY	RYR3	4031	Q15413
KEYVMGLESRVRGLA	CREBZF	226	Q9NS37
IRDRITRLGDVQYKM	TENM4	2241	Q6N022
EVLGLILRYVMERKN	PRKDC	2321	P78527
LDKDIVALMVRRAYD	TOP2A	231	P11388
IEVIYRGAMRGKLIV	TXNL4B	116	Q9NX01
EMVDIIETVYRGARK	TXNL4A	111	P83876